The global market for Oncology Immunotherapy was estimated to be worth US$ 2251 million in 2023 and is forecast to a readjusted size of US$ 3807.5 million by 2030 with a CAGR of 8.3% during the forecast period 2024-2030

Oncology Immunotherapy - Market

Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.

The Oncology Immunotherapy market has expanded as a groundbreaking approach to treating cancer by harnessing the body's immune system to target and fight cancer cells. This innovative therapy includes immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines, among others. By enhancing the immune response against tumors, immunotherapy offers potentially durable and targeted treatments, often with fewer side effects compared to traditional approaches. The market's growth is driven by promising clinical outcomes and a growing understanding of immune-tumor interactions. As researchers continue to explore and refine immunotherapeutic strategies, the Oncology Immunotherapy market remains at the forefront of oncology, revolutionizing cancer treatment paradigms and offering new hope to patients.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology Immunotherapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Oncology Immunotherapy by region & country, by Type, and by Application.

The Oncology Immunotherapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Immunotherapy.

Market Segmentation

Scope of Oncology Immunotherapy - Market Report

Report Metric	Details
Report Name	Oncology Immunotherapy - Market
Forecasted market size in 2030	US$ 3807.5 million
CAGR	8.3%
Forecasted years	2024 - 2030
Segment by Type:	Immune Checkpoint Inhibitors Cytokine-Based Immunotherapy Cancer Vaccines CAR-T Cell Therapy Other
Segment by Application	Hospitals Drugstores Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bristol-Myers Squibb, Merck & Co, Roche AG, AstraZeneca, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oncology Immunotherapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Oncology Immunotherapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Oncology Immunotherapy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Oncology Immunotherapy - Market size in 2030?

Ans: The Oncology Immunotherapy - Market size in 2030 will be US$ 3807.5 million.

Who are the main players in the Oncology Immunotherapy - Market report?

Ans: The main players in the Oncology Immunotherapy - Market are Bristol-Myers Squibb, Merck & Co, Roche AG, AstraZeneca, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA

What are the Application segmentation covered in the Oncology Immunotherapy - Market report?

Ans: The Applications covered in the Oncology Immunotherapy - Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Oncology Immunotherapy - Market report?

Ans: The Types covered in the Oncology Immunotherapy - Market report are Immune Checkpoint Inhibitors, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, Other

1 Market Overview

1.1 Oncology Immunotherapy Product Introduction

1.2 Global Oncology Immunotherapy Market Size Forecast

1.3 Oncology Immunotherapy Market Trends & Drivers

1.3.1 Oncology Immunotherapy Industry Trends

1.3.2 Oncology Immunotherapy Market Drivers & Opportunity

1.3.3 Oncology Immunotherapy Market Challenges

1.3.4 Oncology Immunotherapy Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Oncology Immunotherapy Players Revenue Ranking (2023)

2.2 Global Oncology Immunotherapy Revenue by Company (2019-2024)

2.3 Key Companies Oncology Immunotherapy Manufacturing Base Distribution and Headquarters

2.4 Key Companies Oncology Immunotherapy Product Offered

2.5 Key Companies Time to Begin Mass Production of Oncology Immunotherapy

2.6 Oncology Immunotherapy Market Competitive Analysis

2.6.1 Oncology Immunotherapy Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Oncology Immunotherapy Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Immunotherapy as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Immune Checkpoint Inhibitors

3.1.2 Cytokine-Based Immunotherapy

3.1.3 Cancer Vaccines

3.1.4 CAR-T Cell Therapy

3.1.5 Other

3.2 Global Oncology Immunotherapy Sales Value by Type

3.2.1 Global Oncology Immunotherapy Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Oncology Immunotherapy Sales Value, by Type (2019-2030)

3.2.3 Global Oncology Immunotherapy Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Drugstores

4.1.3 Others

4.2 Global Oncology Immunotherapy Sales Value by Application

4.2.1 Global Oncology Immunotherapy Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Oncology Immunotherapy Sales Value, by Application (2019-2030)

4.2.3 Global Oncology Immunotherapy Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Oncology Immunotherapy Sales Value by Region

5.1.1 Global Oncology Immunotherapy Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Oncology Immunotherapy Sales Value by Region (2019-2024)

5.1.3 Global Oncology Immunotherapy Sales Value by Region (2025-2030)

5.1.4 Global Oncology Immunotherapy Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Oncology Immunotherapy Sales Value, 2019-2030

5.2.2 North America Oncology Immunotherapy Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Oncology Immunotherapy Sales Value, 2019-2030

5.3.2 Europe Oncology Immunotherapy Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Oncology Immunotherapy Sales Value, 2019-2030

5.4.2 Asia Pacific Oncology Immunotherapy Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Oncology Immunotherapy Sales Value, 2019-2030

5.5.2 South America Oncology Immunotherapy Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Oncology Immunotherapy Sales Value, 2019-2030

5.6.2 Middle East & Africa Oncology Immunotherapy Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Oncology Immunotherapy Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Oncology Immunotherapy Sales Value

6.3 United States

6.3.1 United States Oncology Immunotherapy Sales Value, 2019-2030

6.3.2 United States Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Oncology Immunotherapy Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Oncology Immunotherapy Sales Value, 2019-2030

6.4.2 Europe Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Oncology Immunotherapy Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Oncology Immunotherapy Sales Value, 2019-2030

6.5.2 China Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

6.5.3 China Oncology Immunotherapy Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Oncology Immunotherapy Sales Value, 2019-2030

6.6.2 Japan Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Oncology Immunotherapy Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Oncology Immunotherapy Sales Value, 2019-2030

6.7.2 South Korea Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Oncology Immunotherapy Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Oncology Immunotherapy Sales Value, 2019-2030

6.8.2 Southeast Asia Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Oncology Immunotherapy Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Oncology Immunotherapy Sales Value, 2019-2030

6.9.2 India Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

6.9.3 India Oncology Immunotherapy Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Bristol-Myers Squibb

7.1.1 Bristol-Myers Squibb Profile

7.1.2 Bristol-Myers Squibb Main Business

7.1.3 Bristol-Myers Squibb Oncology Immunotherapy Products, Services and Solutions

7.1.4 Bristol-Myers Squibb Oncology Immunotherapy Revenue (US$ Million) & (2019-2024)

7.1.5 Bristol-Myers Squibb Recent Developments

7.2 Merck & Co

7.2.1 Merck & Co Profile

7.2.2 Merck & Co Main Business

7.2.3 Merck & Co Oncology Immunotherapy Products, Services and Solutions

7.2.4 Merck & Co Oncology Immunotherapy Revenue (US$ Million) & (2019-2024)

7.2.5 Merck & Co Recent Developments

7.3 Roche AG

7.3.1 Roche AG Profile

7.3.2 Roche AG Main Business

7.3.3 Roche AG Oncology Immunotherapy Products, Services and Solutions

7.3.4 Roche AG Oncology Immunotherapy Revenue (US$ Million) & (2019-2024)

7.3.5 AstraZeneca Recent Developments

7.4 AstraZeneca

7.4.1 AstraZeneca Profile

7.4.2 AstraZeneca Main Business

7.4.3 AstraZeneca Oncology Immunotherapy Products, Services and Solutions

7.4.4 AstraZeneca Oncology Immunotherapy Revenue (US$ Million) & (2019-2024)

7.4.5 AstraZeneca Recent Developments

7.5 Sanofi S.A.

7.5.1 Sanofi S.A. Profile

7.5.2 Sanofi S.A. Main Business

7.5.3 Sanofi S.A. Oncology Immunotherapy Products, Services and Solutions

7.5.4 Sanofi S.A. Oncology Immunotherapy Revenue (US$ Million) & (2019-2024)

7.5.5 Sanofi S.A. Recent Developments

7.6 Dendreon Pharmaceuticals

7.6.1 Dendreon Pharmaceuticals Profile

7.6.2 Dendreon Pharmaceuticals Main Business

7.6.3 Dendreon Pharmaceuticals Oncology Immunotherapy Products, Services and Solutions

7.6.4 Dendreon Pharmaceuticals Oncology Immunotherapy Revenue (US$ Million) & (2019-2024)

7.6.5 Dendreon Pharmaceuticals Recent Developments

7.7 Novartis

7.7.1 Novartis Profile

7.7.2 Novartis Main Business

7.7.3 Novartis Oncology Immunotherapy Products, Services and Solutions

7.7.4 Novartis Oncology Immunotherapy Revenue (US$ Million) & (2019-2024)

7.7.5 Novartis Recent Developments

7.8 Gilead Sciences Inc.

7.8.1 Gilead Sciences Inc. Profile

7.8.2 Gilead Sciences Inc. Main Business

7.8.3 Gilead Sciences Inc. Oncology Immunotherapy Products, Services and Solutions

7.8.4 Gilead Sciences Inc. Oncology Immunotherapy Revenue (US$ Million) & (2019-2024)

7.8.5 Gilead Sciences Inc. Recent Developments

7.9 Merck KGaA

7.9.1 Merck KGaA Profile

7.9.2 Merck KGaA Main Business

7.9.3 Merck KGaA Oncology Immunotherapy Products, Services and Solutions

7.9.4 Merck KGaA Oncology Immunotherapy Revenue (US$ Million) & (2019-2024)

7.9.5 Merck KGaA Recent Developments

8 Industry Chain Analysis

8.1 Oncology Immunotherapy Industrial Chain

8.2 Oncology Immunotherapy Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Oncology Immunotherapy Sales Model

8.5.2 Sales Channel

8.5.3 Oncology Immunotherapy Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc

Merck KGaA

List of Tables

Table 1. Oncology Immunotherapy Market Trends

Table 2. Oncology Immunotherapy Market Drivers & Opportunity

Table 3. Oncology Immunotherapy Market Challenges

Table 4. Oncology Immunotherapy Market Restraints

Table 5. Global Oncology Immunotherapy Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Oncology Immunotherapy Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Oncology Immunotherapy Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Oncology Immunotherapy Product Type

Table 9. Key Companies Time to Begin Mass Production of Oncology Immunotherapy

Table 10. Global Oncology Immunotherapy Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Immunotherapy as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Oncology Immunotherapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Oncology Immunotherapy Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Oncology Immunotherapy Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Oncology Immunotherapy Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Oncology Immunotherapy Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Oncology Immunotherapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Oncology Immunotherapy Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Oncology Immunotherapy Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Oncology Immunotherapy Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Oncology Immunotherapy Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Oncology Immunotherapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Oncology Immunotherapy Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Oncology Immunotherapy Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Oncology Immunotherapy Sales Value by Region (2019-2024) & (%)

Table 27. Global Oncology Immunotherapy Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Oncology Immunotherapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Oncology Immunotherapy Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Oncology Immunotherapy Sales Value, (2025-2030) & (US$ Million)

Table 31. Bristol-Myers Squibb Basic Information List

Table 32. Bristol-Myers Squibb Description and Business Overview

Table 33. Bristol-Myers Squibb Oncology Immunotherapy Products, Services and Solutions

Table 34. Revenue (US$ Million) in Oncology Immunotherapy Business of Bristol-Myers Squibb (2019-2024)

Table 35. Bristol-Myers Squibb Recent Developments

Table 36. Merck & Co Basic Information List

Table 37. Merck & Co Description and Business Overview

Table 38. Merck & Co Oncology Immunotherapy Products, Services and Solutions

Table 39. Revenue (US$ Million) in Oncology Immunotherapy Business of Merck & Co (2019-2024)

Table 40. Merck & Co Recent Developments

Table 41. Roche AG Basic Information List

Table 42. Roche AG Description and Business Overview

Table 43. Roche AG Oncology Immunotherapy Products, Services and Solutions

Table 44. Revenue (US$ Million) in Oncology Immunotherapy Business of Roche AG (2019-2024)

Table 45. Roche AG Recent Developments

Table 46. AstraZeneca Basic Information List

Table 47. AstraZeneca Description and Business Overview

Table 48. AstraZeneca Oncology Immunotherapy Products, Services and Solutions

Table 49. Revenue (US$ Million) in Oncology Immunotherapy Business of AstraZeneca (2019-2024)

Table 50. AstraZeneca Recent Developments

Table 51. Sanofi S.A. Basic Information List

Table 52. Sanofi S.A. Description and Business Overview

Table 53. Sanofi S.A. Oncology Immunotherapy Products, Services and Solutions

Table 54. Revenue (US$ Million) in Oncology Immunotherapy Business of Sanofi S.A. (2019-2024)

Table 55. Sanofi S.A. Recent Developments

Table 56. Dendreon Pharmaceuticals Basic Information List

Table 57. Dendreon Pharmaceuticals Description and Business Overview

Table 58. Dendreon Pharmaceuticals Oncology Immunotherapy Products, Services and Solutions

Table 59. Revenue (US$ Million) in Oncology Immunotherapy Business of Dendreon Pharmaceuticals (2019-2024)

Table 60. Dendreon Pharmaceuticals Recent Developments

Table 61. Novartis Basic Information List

Table 62. Novartis Description and Business Overview

Table 63. Novartis Oncology Immunotherapy Products, Services and Solutions

Table 64. Revenue (US$ Million) in Oncology Immunotherapy Business of Novartis (2019-2024)

Table 65. Novartis Recent Developments

Table 66. Gilead Sciences Inc. Basic Information List

Table 67. Gilead Sciences Inc. Description and Business Overview

Table 68. Gilead Sciences Inc. Oncology Immunotherapy Products, Services and Solutions

Table 69. Revenue (US$ Million) in Oncology Immunotherapy Business of Gilead Sciences Inc. (2019-2024)

Table 70. Gilead Sciences Inc. Recent Developments

Table 71. Merck KGaA Basic Information List

Table 72. Merck KGaA Description and Business Overview

Table 73. Merck KGaA Oncology Immunotherapy Products, Services and Solutions

Table 74. Revenue (US$ Million) in Oncology Immunotherapy Business of Merck KGaA (2019-2024)

Table 75. Merck KGaA Recent Developments

Table 76. Key Raw Materials Lists

Table 77. Raw Materials Key Suppliers Lists

Table 78. Oncology Immunotherapy Downstream Customers

Table 79. Oncology Immunotherapy Distributors List

Table 80. Research Programs/Design for This Report

Table 81. Key Data Information from Secondary Sources

Table 82. Key Data Information from Primary Sources

Table 83. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Oncology Immunotherapy Product Picture

Figure 2. Global Oncology Immunotherapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Oncology Immunotherapy Sales Value (2019-2030) & (US$ Million)

Figure 4. Oncology Immunotherapy Report Years Considered

Figure 5. Global Oncology Immunotherapy Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology Immunotherapy Revenue in 2023

Figure 7. Oncology Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Immune Checkpoint Inhibitors Picture

Figure 9. Cytokine-Based Immunotherapy Picture

Figure 10. Cancer Vaccines Picture

Figure 11. CAR-T Cell Therapy Picture

Figure 12. Other Picture

Figure 13. Global Oncology Immunotherapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Oncology Immunotherapy Sales Value Market Share by Type, 2023 & 2030

Figure 15. Product Picture of Hospitals

Figure 16. Product Picture of Drugstores

Figure 17. Product Picture of Others

Figure 18. Global Oncology Immunotherapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global Oncology Immunotherapy Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America Oncology Immunotherapy Sales Value (2019-2030) & (US$ Million)

Figure 21. North America Oncology Immunotherapy Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe Oncology Immunotherapy Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe Oncology Immunotherapy Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific Oncology Immunotherapy Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific Oncology Immunotherapy Sales Value by Country (%), 2023 VS 2030

Figure 26. South America Oncology Immunotherapy Sales Value (2019-2030) & (US$ Million)

Figure 27. South America Oncology Immunotherapy Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa Oncology Immunotherapy Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa Oncology Immunotherapy Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions Oncology Immunotherapy Sales Value (%), (2019-2030)

Figure 31. United States Oncology Immunotherapy Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

Figure 33. United States Oncology Immunotherapy Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe Oncology Immunotherapy Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe Oncology Immunotherapy Sales Value by Application (%), 2023 VS 2030

Figure 37. China Oncology Immunotherapy Sales Value, (2019-2030) & (US$ Million)

Figure 38. China Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

Figure 39. China Oncology Immunotherapy Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan Oncology Immunotherapy Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan Oncology Immunotherapy Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea Oncology Immunotherapy Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea Oncology Immunotherapy Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia Oncology Immunotherapy Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia Oncology Immunotherapy Sales Value by Application (%), 2023 VS 2030

Figure 49. India Oncology Immunotherapy Sales Value, (2019-2030) & (US$ Million)

Figure 50. India Oncology Immunotherapy Sales Value by Type (%), 2023 VS 2030

Figure 51. India Oncology Immunotherapy Sales Value by Application (%), 2023 VS 2030

Figure 52. Oncology Immunotherapy Industrial Chain

Figure 53. Oncology Immunotherapy Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

120 Pages

Type: Report

Code: QYRE-Auto-39R14639

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Cancer Early Detection and Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-37I14671

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global One-Stop Radiotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G18542

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-1A14903

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Oncology Immunotherapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-9T10240

Oncology Immunotherapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Oncology Immunotherapy - Market Size

Oncology Immunotherapy - Market

Report Scope

Scope of Oncology Immunotherapy - Market Report

Chapter Outline

FAQ for this report

What is the Oncology Immunotherapy - Market size in 2030?

Who are the main players in the Oncology Immunotherapy - Market report?

What are the Application segmentation covered in the Oncology Immunotherapy - Market report?

What are the Type segmentation covered in the Oncology Immunotherapy - Market report?

FEATURED COMPANIES

RELATED REPORTS